MedTrace Logo

An Examination of a Weight Loss Formula on Health

NCT03395262 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-09-10

No results posted yet for this study

Summary

The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.

Conditions

Interventions

DIETARY_SUPPLEMENT

Active with caffeine

Novel formula with caffeine

DIETARY_SUPPLEMENT

Active without caffeine

Novel formula without caffeine

DIETARY_SUPPLEMENT

Placebo

Dextrose placebo

Sponsors & Collaborators

Principal Investigators

  • Richard B Kreider, PhD · Texas A&M University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-03-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03395262 on ClinicalTrials.gov